MacroGenics Inc Banner Image

MacroGenics Inc

  • Ticker MGNX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
MacroGenics Inc Logo Image
  • 201-500 Employees
  • Based in Rockville, Maryland
MacroGenics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody-based technology platforms.
4.8 / 5.0 (206)

MacroGenics Inc reports have an aggregate usefulness score of 4.8 based on 206 reviews.

MacroGenics Inc

Most Recent Annual Report

MacroGenics Inc
MOST RECENT 2023 Annual Report and Form 10K

MacroGenics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

MacroGenics Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!